Results 141 to 150 of about 332,084 (209)

Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial. [PDF]

open access: yesEClinicalMedicine, 2020
Abarca K   +16 more
europepmc   +1 more source

Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity. [PDF]

open access: yesFront Immunol, 2018
Soto JA   +7 more
europepmc   +1 more source

Antigen 85B of <i>Mycobacterium tuberculosis</i>: From Immunodominant Antigen to Vaccine Candidate. [PDF]

open access: yesVaccines (Basel)
Chauhan V   +6 more
europepmc   +1 more source

MHC-restricted Ag85B-specific CD8<sup>+</sup> T cells are enhanced by recombinant BCG prime and DNA boost immunization in mice. [PDF]

open access: yesEur J Immunol, 2019
Komine-Aizawa S   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy